{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.1444.3.159",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2021-05-21T01:00:57.000-04:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.159",
  "version" : "20210521",
  "name" : "Cabazitaxel Injectable",
  "status" : "active",
  "date" : "2021-05-21T01:00:57-04:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "concept" : [{
        "code" : "1001433",
        "display" : "1.5 ML cabazitaxel 40 MG/ML Injection"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:9ebf7476-871f-408f-85a5-a0d83963dc1d",
    "timestamp" : "2022-09-27T18:38:46-04:00",
    "total" : 1,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09062022",
      "code" : "1001433",
      "display" : "1.5 ML cabazitaxel 40 MG/ML Injection"
    }]
  }
}